This inventor holds 2 USPTO granted patents and 6 published patent applications. Top assignees: Arizona State University, Mayo Foundation for Medical Education and Research, Scottsdale Healthcare Corporation. Active years: 2014-2022.
Company Filing History:



Years Active: 2014-2022
Title: Glen J Weiss: Innovator in Cancer Research
Introduction
Glen J Weiss is a notable inventor based in Phoenix, AZ (US). He has made significant contributions to the field of cancer research, holding 2 patents that focus on innovative methods for assessing and modulating immune responses.
Latest Patents
One of his latest patents is titled "MoT cells as a therapeutic screening tool for regulatory t-cell activity." This invention includes a method for screening agents that modulate Regulatory T cell (Treg) activity. The method involves incubating a population of CD4+ cells isolated from human blood peripheral mononuclear cells in contact with MoT cells, along with agents suspected of modulating Treg activity. The activation of the CD4+ cells is then detected and compared, allowing for the identification of agents that influence Treg activity. Another significant patent is focused on "Methods of assessing a risk of cancer progression." This patent discloses methods and kits that utilize miRNA expression to predict the development of brain metastases in patients with non-small cell lung cancer.
Career Highlights
Glen has worked with prominent organizations such as the Translational Genomics Research Institute and the Mayo Foundation for Medical Education and Research. His work in these institutions has contributed to advancements in genomic research and cancer treatment methodologies.
Collaborations
Glen has collaborated with notable colleagues, including Thai H Ho and Douglas Lake. Their combined expertise has furthered the research and development of innovative solutions in cancer therapy.
Conclusion
Glen J Weiss is a distinguished inventor whose work in cancer research has led to valuable patents and collaborations. His contributions continue to impact the field and offer hope for advancements in cancer treatment.